Little is known about @entity9504 in adult organ transplant recipients. We prospectively assessed @entity9504 in 263 transplant recipients using polymerase chain reaction (PCR) on plasma samples at regular intervals post-transplant. Adenovirus DNA was detected in 19 of 263 @entity1 (7.2%). @entity646 by transplant type was: liver (n = 10 of 121 [8.3%]), kidney (n = 6 of 92 [6.5%]) and heart (n = 3 of 45 [6.7%]). Time to @entity646 onset was within 10 days post-transplant (n = 4), on day 28 (n = 1), on day 100 (n = 7) and between months 6 and 12 (n = 7). At the time of @entity646 , 11 of 19 (58%) @entity1 had no symptoms, 2 of 19 (10.5%) had gastrointestinal (GI) symptoms, 2 of 19 (10.5%) had respiratory symptoms and 4 @entity1 (21%) had vague/non-specific symptoms. All @entity1 recovered spontaneously. Only 1 of 19 (5%) @entity1 had subsequent acute rejection. @entity9504 is relatively common in adult liver, kidney and heart transplant recipients and most @entity281 are asymptomatic, transient and self-limited. No serious clinical sequelae or effects on subsequent acute rejection were observed.

A surveillance study of XXXX in adult solid organ transplant recipients.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infections'] @entity9504 :: ('MESH:D000257', 'Disease') :: ['Adenovirus viremia', 'adenovirus infection', 'adenovirus infections'] @entity646 :: ('MESH:D014766', 'Disease') :: ['Viremia', 'viremia']
@entity9504 :: (MESH:D000257,Disease) :: ['adenovirus infection']
